dc.contributor.author | McDowell, ME | |
dc.contributor.author | Occhipinti, S | |
dc.contributor.author | Gardiner, RA | |
dc.contributor.author | Baade, PD | |
dc.contributor.author | Steginga, SK | |
dc.date.accessioned | 2017-05-03T11:50:18Z | |
dc.date.available | 2017-05-03T11:50:18Z | |
dc.date.issued | 2009 | |
dc.date.modified | 2010-05-19T06:30:17Z | |
dc.identifier.issn | 0961-5423 | |
dc.identifier.doi | 10.1111/j.1365-2354.2008.01046.x | |
dc.identifier.uri | http://hdl.handle.net/10072/29753 | |
dc.description.abstract | First-degree relatives of men with prostate cancer have a higher risk of being diagnosed with prostate cancer than men without a family history. The present review examines the prevalence and predictors of testing in first-degree relatives, perceptions of risk, prostate cancer knowledge and psychological consequences of screening. Medline, PsycInfo and Cinahl databases were searched for articles examining risk perceptions or screening practices of first-degree relatives of men with prostate cancer for the period of 1990 to August 2007. Eighteen studies were eligible for inclusion. First-degree relatives participated in prostate-specific antigen (PSA) testing more and perceived their risk of prostate cancer to be higher than men without a family history. Family history factors (e.g. being an unaffected son rather than an unaffected brother) were consistent predictors of PSA testing. Studies were characterized by sampling biases and a lack of longitudinal assessments. Prospective, longitudinal assessments with well-validated and comprehensive measures are needed to identify factors that cue the uptake of screening and from this develop an evidence base for decision support. Men with a family history may benefit from targeted communication about the risks and benefits of prostate cancer testing that responds to the implications of their heightened risk. | |
dc.description.peerreviewed | Yes | |
dc.description.publicationstatus | Yes | |
dc.format.extent | 138498 bytes | |
dc.format.mimetype | application/pdf | |
dc.language | English | |
dc.language.iso | eng | |
dc.publisher | Wiley Blackwell | |
dc.publisher.place | Oxford, UK | |
dc.publisher.uri | https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2354.2008.01046.x | |
dc.relation.ispartofstudentpublication | Y | |
dc.relation.ispartofpagefrom | 545 | |
dc.relation.ispartofpageto | 555 | |
dc.relation.ispartofissue | 6 | |
dc.relation.ispartofjournal | European Journal of Cancer Care | |
dc.relation.ispartofvolume | 18 | |
dc.rights.retention | Y | |
dc.subject.fieldofresearch | Nursing | |
dc.subject.fieldofresearch | Oncology and carcinogenesis | |
dc.subject.fieldofresearchcode | 4205 | |
dc.subject.fieldofresearchcode | 3211 | |
dc.title | A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer | |
dc.type | Journal article | |
dc.type.description | C1 - Articles | |
dc.type.code | C - Journal Articles | |
gro.faculty | Griffith Health, School of Applied Psychology | |
gro.rights.copyright | © 2009 Wiley-Blackwell Publishing. This is the author-manuscript version of the paper. Reproduced in accordance with the copyright policy of the publisher.The definitive version is available at www.interscience.wiley.com | |
gro.date.issued | 2009 | |
gro.hasfulltext | Full Text | |
gro.griffith.author | Chambers, Suzanne K. | |